Unlock stock picks and a broker-level newsfeed that powers Wall Street.

HKSE - Delayed Quote HKD

Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)

Compare
8.500
+0.010
+(0.12%)
At close: April 11 at 4:08:17 PM GMT+8
Loading Chart for 3613.HK
  • Previous Close 8.490
  • Open 8.490
  • Bid 8.490 x --
  • Ask 8.560 x --
  • Day's Range 8.440 - 8.580
  • 52 Week Range 7.030 - 10.740
  • Volume 1,238,000
  • Avg. Volume 1,409,349
  • Market Cap (intraday) 7.115B
  • Beta (5Y Monthly) 0.43
  • PE Ratio (TTM) 14.17
  • EPS (TTM) 0.600
  • Earnings Date Mar 28, 2025
  • Forward Dividend & Yield 0.35 (4.12%)
  • Ex-Dividend Date May 30, 2025
  • 1y Target Est 11.65

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates retail outlets in Hong Kong and in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand. Beijing Tong Ren Tang Chinese Medicine Company Limited was founded in 1669 and is based in Wan Chai, Hong Kong.

www.tongrentangcm.com

782

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 3613.HK

View More

Performance Overview: 3613.HK

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

3613.HK
3.19%
HANG SENG INDEX (^HSI)
4.26%

1-Year Return

3613.HK
4.73%
HANG SENG INDEX (^HSI)
22.34%

3-Year Return

3613.HK
10.02%
HANG SENG INDEX (^HSI)
1.38%

5-Year Return

3613.HK
9.14%
HANG SENG INDEX (^HSI)
13.93%

Compare To: 3613.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 3613.HK

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    7.12B

  • Enterprise Value

    5.42B

  • Trailing P/E

    14.17

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.41

  • Price/Book (mrq)

    1.75

  • Enterprise Value/Revenue

    3.36

  • Enterprise Value/EBITDA

    8.52

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    31.04%

  • Return on Assets (ttm)

    7.98%

  • Return on Equity (ttm)

    12.80%

  • Revenue (ttm)

    1.61B

  • Net Income Avi to Common (ttm)

    500.28M

  • Diluted EPS (ttm)

    0.600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.83B

  • Total Debt/Equity (mrq)

    2.91%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 3613.HK

View More

Company Insights: 3613.HK

Research Reports: 3613.HK

View More

People Also Watch